Načítá se...

Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial

BACKGROUND: Ivermectin is widely used in mass drug administrations for controlling neglected parasitic diseases, and can be lethal to malaria vectors that bite treated humans. Therefore, it could be a new tool to reduce plasmodium transmission. We tested the hypothesis that frequently repeated mass...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet
Hlavní autoři: Foy, Brian D, Alout, Haoues, Seaman, Jonathan A, Rao, Sangeeta, Magalhaes, Tereza, Wade, Martina, Parikh, Sunil, Soma, Dieudonné D, Sagna, André B, Fournet, Florence, Slater, Hannah C, Bougma, Roland, Drabo, François, Diabaté, Abdoulaye, Coulidiaty, A Gafar V, Rouamba, Nöel, Dabiré, Roch K
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6459982/
https://ncbi.nlm.nih.gov/pubmed/30878222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(18)32321-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!